307 related articles for article (PubMed ID: 36511181)
21. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
Rosenfeld M; Rayner O; Smyth AR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD001912. PubMed ID: 32997797
[TBL] [Abstract][Full Text] [Related]
22. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
Ahmed MI; Mukherjee S
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011581. PubMed ID: 30052271
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Jeffery TC; Chang AB; Conwell LS
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD002010. PubMed ID: 36625789
[TBL] [Abstract][Full Text] [Related]
24. Nebulised hypertonic saline for cystic fibrosis.
Wark P; McDonald VM
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
[TBL] [Abstract][Full Text] [Related]
25. Probiotics for people with cystic fibrosis.
Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
[TBL] [Abstract][Full Text] [Related]
26. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.
Main E; Rand S
Cochrane Database Syst Rev; 2023 May; 5(5):CD002011. PubMed ID: 37144842
[TBL] [Abstract][Full Text] [Related]
27. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.
Ahmed MI; Mukherjee S
Cochrane Database Syst Rev; 2016 Mar; 3():CD011581. PubMed ID: 27003247
[TBL] [Abstract][Full Text] [Related]
28. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
Heneghan M; Southern KW; Murphy J; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD010966. PubMed ID: 37983082
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization.
Loeb MB; Main C; Eady A; Walker-Dilks C
Cochrane Database Syst Rev; 2003; (4):CD003340. PubMed ID: 14583969
[TBL] [Abstract][Full Text] [Related]
30. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
Hurley MN; Smith S; Forrester DL; Smyth AR
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008037. PubMed ID: 32671834
[TBL] [Abstract][Full Text] [Related]
32. Dual antibiotics for bronchiectasis.
Felix LM; Grundy S; Milan SJ; Armstrong R; Harrison H; Lynes D; Spencer S
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012514. PubMed ID: 29889304
[TBL] [Abstract][Full Text] [Related]
33. Antioxidant supplementation for lung disease in cystic fibrosis.
Ciofu O; Smith S; Lykkesfeldt J
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
[TBL] [Abstract][Full Text] [Related]
34. Intermittent prophylactic antibiotics for bronchiectasis.
Spencer S; Donovan T; Chalmers JD; Mathioudakis AG; McDonnell MJ; Tsang A; Leadbetter P
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013254. PubMed ID: 34985761
[TBL] [Abstract][Full Text] [Related]
35. Topical antibiotics for chronic suppurative otitis media.
Brennan-Jones CG; Head K; Chong LY; Burton MJ; Schilder AG; Bhutta MF
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013051. PubMed ID: 31896168
[TBL] [Abstract][Full Text] [Related]
36. Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.
Jones M; Moffatt F; Harvey A; Ryan JM
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD013610. PubMed ID: 37462324
[TBL] [Abstract][Full Text] [Related]
37. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
Smith S; Rowbotham NJ; Regan KH
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD001021. PubMed ID: 29607494
[TBL] [Abstract][Full Text] [Related]
38. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.
Ni H; Aye SZ; Naing C
Cochrane Database Syst Rev; 2022 May; 5(5):CD013506. PubMed ID: 35616126
[TBL] [Abstract][Full Text] [Related]
39. Physical activity and exercise training in cystic fibrosis.
Radtke T; Smith S; Nevitt SJ; Hebestreit H; Kriemler S
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD002768. PubMed ID: 35943025
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Wood DM; Smyth AR
Cochrane Database Syst Rev; 2006 Jan; (1):CD004197. PubMed ID: 16437476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
